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DNA repair and recovery of RNA synthesis in uremic patients. A high
frequency of cancer appears among uremic patients. As depressed
DNA repair ability is thought to be one of the causes for malignancy in
cancer prone diseases, the present study was undertaken to examine
DNA repair in uremic patients. Unscheduled DNA repair synthesis in
peripheral lymphocytes was measured after both ultraviolet (UV) and
gamma irradiations. In hemodialysis (HD) patients the repairs were
normal, but in chronic renal failure (CRF) patients not yet on dialysis
treatment, both UV- and gamma-induced DNA repair abilities were
depressed to about 60% of the control. Recovery of RNA synthesis
after UV irradiation followed the same pattern: it was reduced in CRF
but normal in HD cells. When CRF lymphocytes were incubated in
normal plasma, the UV-stimulated DNA repair improved to a nearly
normal level, whereas incubation of normal cells in CRF plasma
depressed their repair capacity to 70% of the initial level. These results
suggest that a plasmatic substance such as the carcinogenic heterocy-
clic amines may be involved in the impairment of DNA repair in chronic
renal failure.
The present investigation of DNA repair ability in uremic
patients was initiated by the observation that malignancies are
more common in these patients than in the general population
[1-4]. In some cancer prone diseases a close connection was
found between the depressed ability to repair ultraviolet (UV)-
induced DNA lesions and the high incidence of cancer [5—7].
Impaired DNA repair capacity was also reported in several
malignancies [8—10]. In two previous studies [11, 121 carried out
in our laboratory it was found that the UV-induced DNA repair
ability was actually depressed in uremics. The highest depres-
sion was observed in chronic renal failure (CRF) patients who
had not yet started dialysis treatment; in patients on continubus
ambulatory peritoneal dialysis (CAPD) the depression was
smaller, whereas patients on hemodialysis (HD) had a nearly
normal DNA repair. These results were rather unexpected
because the uremic state of the HD patients is neither im-
proved, as compared to that of CRF patients, nor does HD
enhance the immune system [13, 14].
The present study was undertaken in order to reassure the
previous results. A further aim was to check whether the failure
to repair DNA damage caused by UV is exhibited also in a
depressed ability to repair a different kind of lesion caused by
another agent. Ionizing gamma radiation was chosen for this
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purpose. An attempt was made to prove that a plasmatic factor
was involved in these DNA repair discrepancies. Unscheduled
DNA synthesis capacity in nonstimulated short term cultures of
lymphocytes was the method of choice because it is the most
suitable for large scale screening [15]. Finally, measurements of
the recovery of RNA synthesis after UV irradiation were
employed to determine the transcription capacity of the DNA
[16], which demonstrates the repair of the active part of the
DNA rather than the repair of the whole genomic DNA.
Methods
Patients
For the determination of DNA repair, two groups of patients
were investigated: 10 HD patients and 11 patients with CRF
shortly before starting dialysis treatment. Sixteen apparently
healthy blood donors from the local staff and blood bank served
as controls. Details about the patients are presented in Table 1.
Recovery of RNA synthesis was measured in 10 samples of
each group. For the examination of plasmatic influence on the
DNA repair, the test groups were composed of six CRF patients
and six controls.
Cells
DNA repair ability was measured in circulating lymphocytes
after exposure to UV or to gamma irradiation, using modifica-
tions of well established procedures [15, 17—19]. Lymphocytes
were separated from freshly drawn heparinized peripheral
blood on a Ficoll Paque (Pharmacia, Uppsala, Sweden) gradient
[20], and suspended in isotonic phosphate-buffered saline (PBS)
at a concentration of 4 x 106 cells/mI. Portions of 0.5 ml (2 x 106
cells) were applied to each of 8 to 10 Petri dishes (50 mm
diameter, Miniplast, Einshemer, Israel) for UV repair and to 8
to 10 screw cap test tubes (Sterilin, Hounslow, GB) for gamma
repair measurements, and were kept cold.
Irradiations
UV irradiation was produced by a Philips TUV 15 W Gl598
lamp. The intensity was measured by an UVX digital radiom-
eter (UVP Inc., San Gabriel, California, USA). Four or five
replicate plates were opened one at a time and UV irradiated
(250 erg/mm2 at 254 nm) while kept on ice to avoid premature
repair, and were covered from daylight to avoid photoreactiva-
tion. Four or five other replicates of each sample were kept cold
without irradiation. Gamma irradiation was produced by a 60Co
source. Half of the tubes of each sample were exposed to 100
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No. of patients 10 11 16
Age years
Range 29—73 26—78 3 1—73
Mean 62,0 4.4 52.6 4.5 54.7 3.8
GenderF:M 6:4 6:5 10:6
Urea mg/dI 169.8 7.7 107.0 9.7 31.6 2.9
Creatinine mg/dl 12.1 0.8 5.0 0.4 0.9 0.04
Hemoglobin g/d1 9.8 0.5 12.0 0.7 13.1 1.0
Dialysis period years 3.9 0.7 — —
GY gamma irradiation [19, 211 while being kept in an ice bath,
whereas the other half were kept cold without irradiation.
DNA repair synthesis
Two ml cold RPM! 1640 medium, supplemented with 15%
heat-inactivated fetal calf serum, 1% glutamine and 1% antibi-
otic solutions, containing 10,000 U/mi penicillin, 10 mg/ml
streptomycin and 25 pg/mI amphotericin B (Biological Indus-
tries, Belt Haemek, Israel) were added to all the irradiated and
unirradiated samples. Hydroxyurea in PBS solution (Sigma
Chemical Co., St. Louis, Missouri, USA) was added to a final
concentration of 10—2 M to avoid scheduled DNA repair syn-
thesis [15, 19, 22] followed by thymidine (5H-methyl, 10 CiIml,
49 Ci/mmol; Nuclear Research Center, Negev, Israel). Incuba-
tion at 37°C in an atmosphere of 5% CO2 in air took place for
four hours to enable unscheduled DNA repair synthesis, and
then the cells were ice cooled.
In several samples kinetics of irradiation time and of incuba-
tion time were performed to demonstrate irradiation dose curve
and incubation time curve for optimal conditions. The proce-
dure was finished as mentioned elsewhere [111. Shortly, con-
tents of plates were quantitatively transferred to plastic tubes.
All the tubes were centrifuged and the pellets washed with cold
PBS. The washed pellets could be stored for several days at
—20° if needed. The thawed pellets were washed again, then
hydrolyzed for 30 minutes in 0.5 ml 0.5 N NaOH at 37°C,
cooled, neutralized with 0.5 N HC1, precipitated with an equal
volume of cold 20% trichioroacetic acid, kept on ice for at least
one hour, filtered through glass microfiber filters (Whatman,
GF/C-0.25 mm, Tamar, Jerusalem, Israel), washed thoroughly
with cold 10% trichloroacetic acid and finally with cold 95%
ethanol. The dry filters were counted for 3H in a liquid scintil-
lation counter (1217 Rackbeta, LKB, Wallac, Finland). The
yields of the counts were 46 to 48%.
Recovery of RNA synthesis
RNA recovery after UV irradiation was measured according
to the method of Lehmann [23] with modifications which made
it suitable for lymphocytes. Cells were prepared as above and
portions of 250 l (1 x 106 cells) were applied to each of 8 to 10
plates. After irradiation of half of the plates, incubation in 2 ml
whole medium took place for one hour to allow DNA repair.
Then 3H-uridine (5 sCi/ml; 15 Cilmmol; Nuclear Research
Center) was added and incubation continued for another four
hours. Lysis of the washed cells was performed in mild condi-
tions to avoid RNA decomposition as following: 1 ml N/io NaOH





DNA repaira 750 458 753
N 10 8 16





Posthoc comparison by Duncan procedure: F = 4.17; P = 0.025; CRF
<HD; CRF <C.
aThe difference between irradiated and unirradiated lymphocytes of
3H-thymidine incorporation (mean cpm/106 cells), in the presence of
hydroxyurea
was added to one tube at a time, and after thorough mixing for
30 seconds the solution was neutralized with 1 ml N/10 HCI. The
RNA was precipitated with 200 d of 100% trichloroacetic acid
solution in the presence of bovine serum albumine (15 d, 10
mg/mi solution). Filtration, washing and counting of 3H-uridine
was as in DNA repair.
Effect of uremic plasma
For this purpose the incubation medium was supplemented
with human plasma instead of fetal calf serum. In each exper-
iment plates containing lymphocytes from a CRF patient were
UV-irradiated and then supplemented either with medium con-
taining 15% of their own plasma or with a control plasma. Cells
from the same control were supplemented either with their own
plasma or with the CRF plasma. Nonirradiated cells were
treated in the same way. This kind of experiment was repeated
with six CRF patients and six controls.
Statistical analysis
Data are exhibited in cpm. The datum for each condition is a
mean of four to five replicates. DNA repair ability is expressed
as the difference between cpm of irradiated and nonirradiated
samples per 1 x 106 cells. RNA recovery is expressed as the
ratio between cpm of irradiated cells and cpm of nonirradiated
cells.
Statistical comparison between the DNA repairs of the inves-
tigated groups was calculated by one way analysis of variance,
posthoc comparison. The RNA recovery results were also
submitted to ANOVA. P < 0.05 was considered significant.
Significance of correlation coefficients was determined by cal-
culating t values. The influence of plasma on DNA repair was
analyzed by the Mann-Whitney U-test for nonrelated samples
or by Wilcoxon matched T-test for related samples.
Results
DNA repair in HD and CRF patients
DNA repair abilities after UV and after gamma irradiations
are presented in Tables 2 and 3, respectively. Following UV
irradiation, the repair of the CRF lymphocytes was greatly
reduced (458 43 cpm/106 cells), whereas there was no
significant difference between the repair of the cells of HD
patients (750 92) and of the controls (753 62 cpmllO6 cells).
A similar pattern existed after gamma irradiation: The repair of
Table 1. Features of the three study groups (mean SEM)
Control Chronic renal Hemodialysis
failure
Table 3. DNA repair ability of lymphocytes after gamma irradiation








DNA repaira 264 136 221
N 10 11 16





Posthoc comparison by Duncan procedure: F = 7.33; P = 0.0023;
CRF < HD; CRF < C.
a The difference between irradiated and nonirradiated lymphocytes of
3H-thymidine incorporation (mean cpm/106 cells), in the presence of
hydroxyurea
100 200 300 400 900 UV, erg/mm2
Fig. 1. UV and gamma dose-response curves. Results of one repre-
sentative experiment. Each point stands for 5 replicates.
the CRF lymphocytes (136 16 cpm/106 cells) was much
depressed as compared with healthy cells (221 18) while RD
lymphocytes showed a normal repair (264 30 cpm/106 cells).
A very significant positive correlation existed between the
DNA repairs after UV and after gamma irradiations within the
controls and within the HD groups (r = +0.874, P < 0.001 and
r = +0.970, P < 0.001, respectively), whereas in the CRF
groups the correlation between UV and gamma repairs was
lower and not significant (r = +0.703, P = NS). UV and gamma
irradiation-dose response curves were performed in several
samples in order to demonstrate optimal irradiation conditions
(Fig. 1). An irradiation dose of 100 Gy reached the plateau and
was in agreement with the results of other investigators [19, 21]
for double strand break production. UV irradiation dose was
250 erg/mm2, which is above the maximal UV energy which
saturates the UV effect [241, and was used in other repair
studies [11, 15] as well.
Incubation time of four hours was found to be optimal for the
combined repair experiments and was generally accepted to be
in the plateau of unscheduled DNA synthesis. The following
parameters were checked for possible relationship with DNA
repair ability: plasma urea or creatinine levels, hemoglobin
level, the period of time on maintenance HD, age, and gender.
None of them had any correlation with DNA repair, although
some investigators claim that it decreases with age [25, 26]
whereas others disagree [27, 28].
RNA recovery in HD and CRF patients
Recovery of RNA synthesis in lymphocytes from CRF and
HD patients and from controls after UV irradiation is presented
y, Gy in Figure 2. RNA recovery of CRF cells was reduced to 80% of
the recovery of control cells (0.46 0.014 vs. 0.57 0.013
respectively, P < 0.0005), whereas the RD cells did not differ
much from the control (0.61 0.021; P = NS).
In DNA repair measurements the 3H-thymidine counts of
nonirradiated cells never exceeded 100 cpm/106 cells because
DNA synthesis rarely takes place in nonstimulated lympho-
cytes and starts only after UV irradiation for repair purposes. In
RNA recovery tests the 3H-uridine incorporation into the
nonirradiated cells varied from 600 to 3000 cpm/106 cells and
were 1.4 to 2.9 times higher than incorporation into the irradi-
ated ones, thus representing the transcription activity, which
was reduced by the UV irradiation.
Effect of normal and CRF plasma on DNA repair
In some experiments the UV irradiated cells were incubated
in the presence of plasma during the repair process. The repair
ability of CRF lymphocytes in the presence of normal plasma as
compared with incubation in their own plasma is presented in
Table 4, and the effect of the CRF plasma on normal cells is
demonstrated as well. These results can be concluded as
following: (1) The DNA repair ability of CRF cells in their own
plasma (594 20) was only one half the ability of normal cells
in their plasma (1154 114, A vs. C; P < 0.001). (2) Incubation
of the CRF cells in normal plasma elevated their repair ability
from 594 20 to 831 58 cpm/l06 cells (A vs. B; P < 0.025).
(3) Incubation of the normal cells in plasma of CRF patients
decreased their repair ability from 1154 114 to 811 84





Fig. 2. Recovery of RNA synthesis in lymphocytes from control,
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In the present study the repair ability of damaged DNA,
induced both by UV and gamma irradiations, was found to be
depressed to 60% of the normal values in peripheral lympho-
cytes from CRF patients with high urea and creatinine levels.
On the other hand, uremic patients on maintenance hemodial-
ysis treatment demonstrated a normal repair capacity after both
types of irradiation. Depressed ability to repair DNA damage is
associated with cancer and with cancer prone diseases [5—10],
and is considered to be one of the causes of malignancy. As
cancer in uremic patients appears more often than in others
[1—4] the present study was initiated to find out whether these
patients also belong to the group of high risk for cancer
combined with low DNA repair ability. The first studies were
performed several years ago, with only UV irradiation initiating
the repair [11, 12], and their results opposed the working
hypothesis which anticipated HD and CRF cells to behave
similarly. The present UV repair ability of the experimental and
control groups reassured the unexpected improvement of DNA
repair ability in uremic patients who were on HD treatment in
comparison with pre-dialysis CRF. The gamma-induced DNA
repair showed the same relationships between the different
groups as did the UV repair, but with lower absolute values
(Fig. 3). The difference in 3H-thymidine counts of the UV
induced repair between the published results and the recent
experiments can be attributed to changes in the procedure
which had to be made in order to enable simultaneous UV and
gamma repairs. The DNA repair measurement demonstrates
the ability of the whole genome to repair itself after being
damaged by mutagenic agents, but it does not discriminate
between the actively transcribed part and the nonactive part of
the DNA. Hence the recovery of RNA synthesis after UV
irradiation was determined to find out whether the DNA repair
process included both transcribed and nontranscribed DNA
[16]. Our results show that RNA recovery in HD cells was equal
to that in the normal cells, but in lymphocytes from CRF
patients it was reduced to 80% of the control. Twenty percent
reduction of RNA synthesis may have a major peripheral
expression. Both methods together shed some light on the
differential ability of the cells to repair active or inactive genes.
Screening the lists of medications, medical treatments, pre-
vious low dose radiations and exposure to metal ions or to other
compounds have not provided a satisfactory explanation to the
elevated DNA repair in HD in comparison with CRF patients.
Yet several reasons for such findings can be raised, among
which are the beneficial influence of the dialyzer on superoxide
anion generation during HD [29, 30], or the presence of high
concentrations of heterocyclic amines in CRF patients [31—36].
These compounds are known to interact with DNA and form
adducts. High levels of heterocyclic amines in uremic blood
was suggested as a hypothesis to explain the high incidence of
cancer among these patients [1]. The fact that CRF patients do
not exhibit more malignancies than the HD patients may be
explained by the possibility that some mutational changes,
which start at the CRF stage, become overt only later while
undergoing HD.
In conclusion, CRF patients have an impaired DNA repair
ability which is improved by HD. The reduced DNA repair may
be one of the causes for the high cancer incidence among
uremic patients.
Reprint requests to Joseph Levi, M.D., Department of Nephrology,
Hasharon Hospital, Petal)-Tiqva 49372, P.O.B. 121, Israel.
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